Please login to the form below

Not currently logged in

Big opportunities in big data, but EMA and industry just getting started

250m genomes sequenced, but data trapped in silos

Novartis’ Egatan gains US approval for neglected tropical disease

Novartis HQUS approval removes barrier to greater access

Industry aghast as EU Parliament backs biosimilar rule change

EFPIA logoThe change could come into effect in 2021

Industry concerned about ‘rushed’ Brexit withdrawal legislation

implicationsThe Patents Amendment could weaken the UK’s IP framework, warns biopharma

Finch’s microbiota drug for C. diff gets FDA breakthrough status

Boost for firm as it races rivals in microbiome space

No deal Brexit would see UK miss out on ‘safest medicines system in the world’

drugdHealth leaders say it would be 'a travesty'

NICE and Canadian counterpart to offer joint advice service

NICE (National for Health and Clinical Excellence)Agencies offer parallel scientific advice

Pfizer closes on EU approval of lung cancer drug Vizimpro

ema1And AZ claims first with Forxiga in T1 diabetes

Brexit‘Post-Brexit landscape for EU-wide IP Rights: The Story So Far’

Brexit means pharma must review its intellectual property rights across Europe

Latest regulatory appointments

Featured jobs

Subscribe to our email news alerts


Add my company
Life Healthcare Communications

Life is a creative communications agency offering multi-channel solutions for the healthcare industry. We use a storytelling approach to turn...

Latest intelligence

Three billboards on the road to multichannel
Chris Ross examines the trends driving multichannel communication in 2019...
How Medisafe is using AI to improve patient adherence
Dina Patel speaks to Omri Shor, Co-Founder and CEO of Medisafe, to find out how his medication management app is tackling the problem of poor adherence....
Cell and gene therapy
Tackling the manufacturing cost and complexity challenges...